-
Vanderbilt-MJFF Partnership Yields Drug-Like Molecules Aimed at Improving Treatment of Parkinson's Disease
September 30, 2011
… dopamine replacement therapy, by bypassing the dopamine system altogether and instead modulating another of the … Vanderbilt researchers describe three PAMs that, when given systemically in a preclinical model of Parkinson’s disease, …
-
Early Investment from Michael J. Fox Foundation Pushes New Parkinson's Treatment to Market
December 26, 2018
… 2011 and 2013 with two grants totaling $1.3 million. After multiple rounds of venture capital investment, Acorda …
-
Australian Parkinson's Mission Integrates Breakthrough Genomics and Clinical Trials
January 30, 2019
… Parkinson’s in 2009, says, “This five year program includes multiple clinical trials of potentially disease modifying …
-
The Michael J. Fox Foundation Awards $1.6 Million to Research Biomarker for Parkinson's Disease
January 30, 2003
… designed the initiative to encourage the development of multiple types of biomarkers, applications were reviewed …
-
Michael J. Fox Foundation for Parkinson’s Research Commits up to $2 Million to Visualize Alpha-Synuclein Protein in the Brain
June 3, 2008
… successful applications to this program will likely require multiple areas of expertise, such as clinical and …
-
The Michael J. Fox Foundation Launches the $14 Million-Edmond J. Safra Core Programs for PD Research
June 20, 2012
… by allowing successful projects to continue through multiple phases of the drug development process without …